Poniard Pharmaceuticals (OTC: PARD)
$0.00
(0.0%)
$0.00
Price as of April 7, 2025, 2:05 p.m. ET
Poniard Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Poniard Pharmaceuticals Company Info
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of oncology products. The company is currently focusing on developing picoplatin, a new and differentiated platinum-based chemotherapeutic agent that is used in the clinical development for multiple cancer indications, treatment combinations, and by different routes of administration. The company was founded in 1984 and is headquartered in Seattle, WA.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.